Cita APA

Kovatchev, B. P., Crean, J., & McCall, A. (2008). Pramlintide Reduces the Risks Associated with Glucose Variability in Type 1 Diabetes. Mary Ann Liebert, Inc.

Citación estilo Chicago

Kovatchev, Boris P., John Crean, y Anthony McCall. Pramlintide Reduces the Risks Associated With Glucose Variability in Type 1 Diabetes. Mary Ann Liebert, Inc, 2008.

Cita MLA

Kovatchev, Boris P., John Crean, y Anthony McCall. Pramlintide Reduces the Risks Associated With Glucose Variability in Type 1 Diabetes. Mary Ann Liebert, Inc, 2008.